HER2 NEGATIVE BREAST CARCINOMA

This early-stage study is testing the safety and immune response of a new vaccine called STEMVAC in patients with advanced HER2-negative breast cancer. The vaccine aims to train the body's immune system to recognize and attack cancer cells, particularly those that are resistant t…

This large study is testing whether a lower dose of the hormone-blocking drug tamoxifen works as well as standard hormone therapy for preventing breast cancer from returning. It involves over 1,100 postmenopausal women with early-stage, low-risk breast cancer. The goal is to see …

This early-stage trial is testing whether adding an experimental drug called berzosertib to standard radiation therapy can better control breast cancer that has not responded well to chemotherapy. The main goal is to find the safest and most effective dose of the drug when given …

This study is testing whether simple support tools can help breast cancer patients remember to take their daily hormone therapy pills correctly. Researchers are comparing text message reminders, phone-based counseling sessions, or both, against standard care to see which method w…

This study is testing a shorter, more convenient radiation schedule for women with early-stage, low-risk breast cancer. It aims to see if giving radiation once a day for five days in a row works as well as the standard every-other-day schedule, with a focus on maintaining a good …

This study is testing a blood test that looks for tiny pieces of leftover cancer DNA after treatment for early-stage breast cancer. The goal is to see if this test can identify patients who still have hidden cancer cells and might benefit from additional therapy. Researchers will…